Hyperlactatemia clinical trials

Explore recruiting hyperlactatemia clinical trials.

Recruiting hyperlactatemia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Hyperlactatemia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

PDH-RAVICTI - A PHASE II, MULTICENTRIC, PROSPECTIVE, NON-COMPARATIVE CLINICAL TRIAL TO ASSESS THE EFFICACY AND SAFETY OF THE TREATMENT OF PYRUVATE DEHYDROGENASE DEFICIENCY (PDH) PATIENTS WITH GLYCEROL PHENYLBUTYRATE (RAVICTI®)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Hyperlactatemia trials by city

Hyperlactatemia in Toronto Hyperlactatemia in Vancouver Hyperlactatemia in Montreal Hyperlactatemia in Calgary Hyperlactatemia in Edmonton Hyperlactatemia in Ottawa Hyperlactatemia in Winnipeg Hyperlactatemia in Quebec City Hyperlactatemia in Hamilton Hyperlactatemia in Kitchener Hyperlactatemia in London Hyperlactatemia in Halifax Hyperlactatemia in New York Hyperlactatemia in Los Angeles Hyperlactatemia in Chicago Hyperlactatemia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease